These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2707286)

  • 1. Juvenile chronic myeloid leukaemia and alpha-interferon.
    Aricò M; Nespoli L; Caselli D; Bonetti F; Porta FA; Burgio GR
    Eur J Pediatr; 1989 Jan; 148(4):379-80. PubMed ID: 2707286
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular evidence of transient complete remission after autografting in Ph-/bcr rearranged chronic myelogenous leukaemia.
    Lo Coco F; Saglio G; De Fabritiis P; Diverio D; Guerrasio A; Rosso C; Meloni G; Mancini M; Mandelli F
    Br J Haematol; 1989 Jun; 72(2):285-6. PubMed ID: 2667624
    [No Abstract]   [Full Text] [Related]  

  • 3. [The assessment of therapeutic success in chronic myeloid leukemia].
    Griesshammer M; Hehlmann R; Heimpel H
    Dtsch Med Wochenschr; 1995 Apr; 120(17):620-5. PubMed ID: 7537652
    [No Abstract]   [Full Text] [Related]  

  • 4. [The treatment of chronic myeloid leukemia in chronic phase with interferons].
    Guilhot F
    Pathol Biol (Paris); 1988 Dec; 36(10):1179-81. PubMed ID: 3070457
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon-alpha plus low-dose cytosine arabinoside in advanced phase chronic myelogenous leukaemia patients.
    Ferrajoli A; Liberati AM; Caricchi P; Donti E; Morra E; Lazzarino M; Betti AR; Bernasconi P; Saglio G
    Eur J Haematol; 1995 Sep; 55(3):184-8. PubMed ID: 7672091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-interferon antibodies in alpha interferon treated patients with chronic myeloid leukaemia.
    Aitchison R; Allen P; Schey S; Newland AC
    Br J Haematol; 1991 Jul; 78(3):465-7. PubMed ID: 1873235
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy with recombinant interferon alpha-2c during unexpected pregnancy in a patient with chronic myeloid leukaemia.
    Reichel RP; Linkesch W; Schetitska D
    Br J Haematol; 1992 Oct; 82(2):472-3. PubMed ID: 1419831
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of chronic myeloid leukemia with cytogenetic remission and disappearance of Ph1 positive cells due to interferon-alpha administration].
    Yoshida M; Fujiwara Y; Yoshinaga H; Maeda T; Mori Y; Nonaka K; Senoo K; Atsui F
    Nihon Naika Gakkai Zasshi; 1991 May; 80(5):766-7. PubMed ID: 1875114
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity of alpha-interferons in chronic myelogenous leukaemia.
    Talpaz M
    Br J Clin Pract Suppl; 1988 Mar; 62():13-5. PubMed ID: 3145008
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver failure due to recombinant alpha interferon for chronic myelogenous leukaemia.
    Wandl UB; Kloke O; Niederle N
    Lancet; 1992 Jan; 339(8785):123-4. PubMed ID: 1345846
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute myeloblastic leukaemia without Philadelphia chromosome developing after interferon therapy for chronic myelocytic leukaemia with Philadelphia chromosome.
    Ohtsuka E; Kikuchi H; Abe Y; Moriyama K; Ohno E; Hirota K; Tezono K; Nasu M
    Br J Haematol; 1995 Aug; 90(4):951-3. PubMed ID: 7669678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CML: new biologic therapies, endpoints and questions.
    Martin A; Cheson BD
    Oncology (Williston Park); 1987 Sep; 1(7):12-3, 16. PubMed ID: 3152809
    [No Abstract]   [Full Text] [Related]  

  • 13. Elimination by interferon-alpha of malignant clone in chronic myeloid leukaemia.
    Opalka B; Kloke O; Bartram CR; Beer U; Janssen JW; Niederle N; Wandl UB
    Lancet; 1989 Jun; 1(8650):1334. PubMed ID: 2566865
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic myeloid leukemia 2011: successes, challenges, and strategies--proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop.
    Mughal TI; Radich JP; Van Etten RA; Quintás-Cardama A; Skorski T; Ravandi F; DeAngelo DJ; Gambacorti-Passerini C; Martinelli G; Tefferi A
    Am J Hematol; 2011 Sep; 86(9):811-9. PubMed ID: 21850662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon in the treatment of chronic myeloid leukemia. Proceedings of a workshop. February 4-7, 1993, Flims, Switzerland.
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):1-54. PubMed ID: 8235695
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy of chronic myelogenous leukaemia with interferons.
    Talpaz M; Kurzrock R; Kantarjian H; Gutterman J
    Cancer Surv; 1989; 8(4):793-8. PubMed ID: 2701727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation.
    Borgies P; Ferrant A; Delannoy A; Van den Berghe H; Michaux JL
    Bone Marrow Transplant; 1989 Jan; 4(1):127-8. PubMed ID: 2647178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotherapy of chronic myelogenous leukemia with interferon.
    Ozer H
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):14-20. PubMed ID: 2461592
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment of chronic myeloleukemia with recombinant alfa-2 interferon].
    Strozha I; Petukhov V; Bondare D; Feldmane G; Duks A; Teilane I; Medne I; Mauritsas M; Grinberga L
    Ter Arkh; 1993; 65(10):62-6. PubMed ID: 8296238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetics and molecular analysis in chronic myelogenous leukemia patients treated by interferon and chemotherapy.
    Guilhot F; Ahmad M; Mahon FX; Dreyfus B; Brizard A; Huret JL; Kitzis A; Tanzer J
    Nouv Rev Fr Hematol (1978); 1990; 32(5):287-8. PubMed ID: 2099398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.